Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Bionano Genomics Inc BNGO

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

Bionano Genomics Appoints Kristiina Vuori, MD, PhD, to its Board of Directors

GlobeNewswire June 12, 2019

Bionano Genomics Reports First Quarter 2019 Financial Results and Provides Business Update

GlobeNewswire May 9, 2019

Bionano Genomics to Report First Quarter 2019 Financial Results and Host a Conference Call and Webcast on May 9

GlobeNewswire May 3, 2019

Consortium Study Finds Bionano Genomics' Optical Mapping Essential for Comprehensive Detection of Structural Variants

GlobeNewswire April 17, 2019

Bionano Genomics to Present at the 31st Annual ROTH Conference

GlobeNewswire March 18, 2019

Bionano Genomics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018

Business Wire March 14, 2019

Bionano Genomics Enters Into Debt and Equity Financing Agreements Totaling $41.5 Million in Commitments

Business Wire March 14, 2019

Bionano Genomics to Report Fourth Quarter and Fiscal Year 2018 Financial Results and Host a Conference Call and Webcast on March 14, 2019

GlobeNewswire March 11, 2019

Bionano Genomics to Present at the Cowen and Company 39th Annual Health Care Conference

GlobeNewswire March 6, 2019

The Largest Study Conducted with Bionano’s Platform to Date Reveals Never-Before-Seen Human Genomic Structural Variations

GlobeNewswire March 5, 2019

Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics

GlobeNewswire March 1, 2019

Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot

GlobeNewswire February 6, 2019

Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications

GlobeNewswire January 14, 2019

Report: Exploring Fundamental Drivers Behind CCA Industries, Goodrich Petroleum, Intelligent, China Automotive, Bionano Genomics, and Gates Industrial — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire November 13, 2018

Bionano Genomics Releases Operating Results for Third Quarter 2018

GlobeNewswire November 7, 2018

Bionano Genomics to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018

GlobeNewswire October 25, 2018

UPDATE – GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China

GlobeNewswire October 19, 2018

GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China

GlobeNewswire October 19, 2018

Bionano and Genoox Launch Integrated Platform for Identification of Structural Variants in DNA

GlobeNewswire October 17, 2018

Bionano Genomics’ Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease

GlobeNewswire October 16, 2018